Overview
biomodal offers the duet multiomics solution, +modC, which simultaneously captures genetic and epigenetic data (A, C, G, T, 5mC, 5hmC) from a single low-volume DNA sample (as low as 5ng) in one sequencing run. This technology enables comprehensive analysis for applications in cancer research, precision medicine, and disease biology studies. Formerly Cambridge Epigenetix, biomodal provides tools that enhance accuracy, efficiency, and depth of biological insights for life sciences and pharma R&D.
Frequently asked questions
- What is biomodal's core technology?
- biomodal's duet multiomics solution, +modC, is a single-base-resolution sequencing technology that reads genetic (A, C, G, T) and epigenetic (5mC, 5hmC) information simultaneously from a single 5ng DNA sample in one workflow.
- What are the key applications for biomodal's solutions?
- Key applications include cancer research (DNA methylation alterations), precision medicine (tailored treatments using genetics and epigenetics), and studies in ageing, normal biology, and disease.
- What sample input is required for biomodal's sequencing?
- The technology requires just 5ng of DNA for multiomic analysis, enabling high sensitivity from low-volume samples.